BUY SIDE BRO

Diageo plc DEO

Latest Deep Dive · Written · AI research note

Bro's Verdict
Deep Dive

Rating

HOLD

Confidence

62%

Target Price

$92.00

Upside

+3.7%

Horizon

medium

Diageo is a high quality franchise but trades at a full 17.7x NTM P/E on just 6.3% EPS growth and 1.1% revenue growth, with the forward multiple 14% above its 2y average, so the market has already re-rated the shares ahead of a fundamental turn that is not yet visible. The analyst's fair value of ~$92 (range $85-$100) implies only low single digit upside from $88.73, below the narrow $99 consensus target that rests on just 5 analysts. With balanced risk/reward — Guinness and premium tequila momentum plus margin recovery against a weak top line, FX/tariff headwinds and elevated leverage — the call is Hold, with accumulation preferred below $80.

Executive Summary

•Diageo trades at 17.7x NTM P/E on just 6.3% forward EPS growth, a PEG near 2.8x that already prices a recovery the top line does not yet confirm, with NTM revenue guided to +1.1%
•Organic operating margin expanded 116bps in FY2026 on cost savings, but reported operating profit fell 27.2% on exceptional restructuring, so headline earnings materially understate the underlying franchise
•Momentum is improving at the margin: NTM EPS revisions +2.5% over 1m to $5.09, shares +12% over 6m, and consensus PT $99 implies ~12% upside against a net constructive 18 Buy / 16 Hold / 3 Sell skew
•The swing factors are US spirits destocking, FX translation and US tariffs, while Guinness and premium tequila (Don Julio, Casamigos) are the durable growth engines carrying the mix

Financial Snapshot

•Revenue (TTM): $19.64b (broadly flat YoY)
•Gross margin: 59.8%
•Operating margin: 27.0%
•Net margin: 8.8%
•ROE: 15.0%
•Debt/Equity: 171.3% (elevated leverage)
•Forward EPS (NTM): $5.00
•Forward EPS growth: +6.3%
•FY+2 EPS estimate: $5.32
•Implied market cap: ~$49b (from 2.58x NTM P/S on $19.10b forward revenue); the reported $911.56b figure is inconsistent with the ADR price and share count and is disregarded
•Quarterly revenue: Q1 $5.82b, Q3 $5.58b, Q4 $4.71b (Q2 and quarterly net income not disclosed)

Forward Outlook

•NTM revenue: $19.10b (+1.1% YoY), a low growth base
•FY+2 revenue: $19.30b (+1.0%), implying a near flat top line through the forecast window
•NTM EPS: $5.00 consensus, with the latest revision already at $5.09
•FY+2 EPS: $5.32 (+6.4% off NTM), implying mid single digit earnings compounding
•Organic operating margin: +116bps in FY2026, with further cost savings expected to offset tariffs and adverse mix
•US spirits: destocking headwind lapping, volume recovery is the key swing factor for the NTM year
•Dividend: reportedly reset lower, signalling balance sheet caution and a reinvestment priority over income

Valuation Analysis

•NTM P/E: 17.7x
•NTM P/S: 2.58x
•NTM EV/EBIT: not reliably disclosed (reported relative EV multiples appear distorted and are not usable)
•TTM P/E: not meaningful, trailing earnings are depressed by restructuring charges; the 17.7x multiple is a forward (NTM) figure
•Relative P/E: 17.4x forward vs 2y average 15.3x (+14%, +0.6 SD), so the stock trades above its own history despite weak growth; implied price at the 2y average is $78.16
•PEG: ~2.8x (17.7x P/E / 6.3% EPS growth), expensive on a growth adjusted basis
•DCF fair value: ~$85 to $95 (WACC 9.5%, terminal growth 2.5%, ~6% EPS CAGR)
•Consensus PT: $99 (median $99, range $99 to $99, unusually narrow)
•Peer comparisons (trailing multiples, as forward peer data not disclosed):

- STZ: ~11.7x TTM P/E, US beer and spirits, market cap $21.4b

- BUD: ~17.1x TTM P/E, global beer scale, market cap $154.2b

- RI.PA: ~13.3x TTM P/E, premium spirits peer, market cap $15.7b

Key Risks & Catalysts

Risks

•US spirits destocking persists longer than expected, delaying volume recovery
•FX translation headwinds from a strong USD against emerging market currencies
•US tariffs on scotch, tequila and imported spirits compress margins
•Elevated leverage (D/E 171.3%) limits flexibility, especially after a reported dividend reset
•Premiumisation stalls as younger cohorts drink less and GLP-1 drugs reduce consumption
•13F ownership collapse (708 positions closed QoQ) signals institutional de risking
•Thin analyst coverage (5 estimates) raises consensus dispersion risk

Catalysts

•US spirits volume recovery as destocking laps
•Guinness and beer momentum sustaining double digit growth in UK and Ireland
•Tequila premiumisation (Don Julio, Casamigos) with demonstrated pricing power
•Latin America and Africa organic growth durability
•Cost savings programme delivering further margin expansion
•Positive EPS revisions continuing (+2.5% over 1m)
•Consensus PT $99 and a net Buy skew supporting sentiment

Investment Thesis

Diageo is a high quality franchise trading at a full price for modest growth. The 17.7x NTM P/E on 6.3% EPS growth and 1.1% revenue growth embeds a recovery that is not yet visible in the numbers, and the forward P/E of 17.4x sits 14% above its 2y average, so the market has already re rated the shares ahead of the fundamental turn. The 27.2% reported operating profit decline, driven by exceptional restructuring, flatters neither the headline nor the optics, even though organic margin expanded 116bps on cost savings.

The offsetting positives are real. NTM EPS revisions have turned positive, the shares have rallied 12% over 6m, and the sell side is net constructive with a $99 consensus target. Guinness and premium tequila are genuine growth engines, and the cost savings programme is doing the heavy lifting on margin while tariffs and mix drag. The key question is whether US spirits destocking laps in time to convert improving sentiment into actual volume recovery.

I rate Diageo a Hold. Fair value is ~$92 (range $85 to $100), implying low single digit upside from $88.73. This sits below the $99 consensus target because my DCF and the 2y average multiple both point to a lower central value, and the narrow $99 to $99 consensus range rests on only 5 analysts. The risk/reward is balanced: quality brands and margin recovery against a full multiple, a weak top line, FX and tariff headwinds, and elevated leverage. I would look to accumulate below $80, where the P/E compresses toward the 2y average and the growth adjusted valuation becomes defensible.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Run your own analysis free

Buy Side Bro writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

iPhone app coming soon. The same account and subscription carry over.

See the latest research on other stocks